Cargando…
Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
BACKGROUND: The role of the sputum microbiome in chronic obstructive pulmonary disease (COPD) progression remains elusive. As the advent of the new culture-independent microbial sequencing technique makes it possible to disclose the complex microbiome community of the respiratory tract. The aim of t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675190/ https://www.ncbi.nlm.nih.gov/pubmed/36403054 http://dx.doi.org/10.1186/s12931-022-02246-9 |
_version_ | 1784833317050253312 |
---|---|
author | Li, Wei Wang, Bingbing Tan, Min Song, Xiaolian Xie, Shuanshuan Wang, Changhui |
author_facet | Li, Wei Wang, Bingbing Tan, Min Song, Xiaolian Xie, Shuanshuan Wang, Changhui |
author_sort | Li, Wei |
collection | PubMed |
description | BACKGROUND: The role of the sputum microbiome in chronic obstructive pulmonary disease (COPD) progression remains elusive. As the advent of the new culture-independent microbial sequencing technique makes it possible to disclose the complex microbiome community of the respiratory tract. The aim of this study was to use metagenomic next-generation sequencing (mNGS) to confirm whether there are differences in sputum microbiome of COPD between different exacerbation frequencies and lung function. METHODS: Thirty-nine COPD patients were divided into a frequent exacerbators (FE) group (n = 20) and a non-frequent exacerbators (NFE) (n = 19) group according to their exacerbation history, or a mild group (FEV(1)/pre ≥ 50%, n = 20) and a severe group (FEV(1)/pre < 50%, n = 19) according to the lung function. Sputum was collected during their stable phase, followed by DNA extraction, untargeted metagenomic next-generation sequencing (mNGS) and bioinformatic analysis. RESULTS: mNGS identified 3355 bacteria, 71 viruses and 22 fungi at the specie level. It was found that Shannon index and Simpson index in FE group was lower than that in NFE group (p = 0.005, 0.008, respectively) but similar between mild and severe groups. Out of top 10 bacteria taxa, Veillonella, Fusobacterium and Prevotella jejuni had a higher abundance in NFE group, Rothia had a higher abundance in mild group. Linear discriminant analysis revealed that many bacterial taxa were more abundant in NFE group, and they mostly belonged to Actinobacteria, Bacteroidetes and Fusobacteria phyla. Frequency of exacerbations was also found to be negatively correlated with alpha diversity (with Shannon index, r = − 0.423, p = 0.009; with Simpson index, r = − 0.482, p = 0.002). No significant correlation was observed between alpha diversity and FEV(1)/pre. CONCLUSIONS: Microbiome diversity in FE group was lower than that in NFE group. There was a significant difference in microbiome taxa abundance between FE and NFE groups, or mild and severe groups. These findings demonstrated that sputum microbiome community dysbiosis was associated with different exacerbation frequencies and lung function in stable COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02246-9. |
format | Online Article Text |
id | pubmed-9675190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96751902022-11-20 Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study Li, Wei Wang, Bingbing Tan, Min Song, Xiaolian Xie, Shuanshuan Wang, Changhui Respir Res Research BACKGROUND: The role of the sputum microbiome in chronic obstructive pulmonary disease (COPD) progression remains elusive. As the advent of the new culture-independent microbial sequencing technique makes it possible to disclose the complex microbiome community of the respiratory tract. The aim of this study was to use metagenomic next-generation sequencing (mNGS) to confirm whether there are differences in sputum microbiome of COPD between different exacerbation frequencies and lung function. METHODS: Thirty-nine COPD patients were divided into a frequent exacerbators (FE) group (n = 20) and a non-frequent exacerbators (NFE) (n = 19) group according to their exacerbation history, or a mild group (FEV(1)/pre ≥ 50%, n = 20) and a severe group (FEV(1)/pre < 50%, n = 19) according to the lung function. Sputum was collected during their stable phase, followed by DNA extraction, untargeted metagenomic next-generation sequencing (mNGS) and bioinformatic analysis. RESULTS: mNGS identified 3355 bacteria, 71 viruses and 22 fungi at the specie level. It was found that Shannon index and Simpson index in FE group was lower than that in NFE group (p = 0.005, 0.008, respectively) but similar between mild and severe groups. Out of top 10 bacteria taxa, Veillonella, Fusobacterium and Prevotella jejuni had a higher abundance in NFE group, Rothia had a higher abundance in mild group. Linear discriminant analysis revealed that many bacterial taxa were more abundant in NFE group, and they mostly belonged to Actinobacteria, Bacteroidetes and Fusobacteria phyla. Frequency of exacerbations was also found to be negatively correlated with alpha diversity (with Shannon index, r = − 0.423, p = 0.009; with Simpson index, r = − 0.482, p = 0.002). No significant correlation was observed between alpha diversity and FEV(1)/pre. CONCLUSIONS: Microbiome diversity in FE group was lower than that in NFE group. There was a significant difference in microbiome taxa abundance between FE and NFE groups, or mild and severe groups. These findings demonstrated that sputum microbiome community dysbiosis was associated with different exacerbation frequencies and lung function in stable COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02246-9. BioMed Central 2022-11-19 2022 /pmc/articles/PMC9675190/ /pubmed/36403054 http://dx.doi.org/10.1186/s12931-022-02246-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Li, Wei Wang, Bingbing Tan, Min Song, Xiaolian Xie, Shuanshuan Wang, Changhui Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study |
title | Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study |
title_full | Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study |
title_fullStr | Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study |
title_full_unstemmed | Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study |
title_short | Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study |
title_sort | analysis of sputum microbial metagenome in copd based on exacerbation frequency and lung function: a case control study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675190/ https://www.ncbi.nlm.nih.gov/pubmed/36403054 http://dx.doi.org/10.1186/s12931-022-02246-9 |
work_keys_str_mv | AT liwei analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy AT wangbingbing analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy AT tanmin analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy AT songxiaolian analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy AT xieshuanshuan analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy AT wangchanghui analysisofsputummicrobialmetagenomeincopdbasedonexacerbationfrequencyandlungfunctionacasecontrolstudy |